Anteris Technologies price target lowered to $15 from $20 at Lake Street

Group 1 - Lake Street analyst Frank Takkinen lowered the price target on Anteris Technologies (AVR) to $15 from $20 while maintaining a Buy rating on the shares [1] - The $320 million in gross financing, which included a $90 million strategic investment from Medtronic (MDT), is described as "a transformational deal for Anteris" [1] - The financing is said to relieve the capital overhang, verify the product's viability, and entrench Medtronic as a collaborator and potential acquirer [1]